Bio-Rad Labs (BIO) Misses Q2 EPS by 52c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $279.73 -0.46%
EPS Growth %: -30.8%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -30.8%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.61, $0.52 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $516.8 million versus the consensus estimate of $497.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Park National Corp. (PRK) Tops Q1 EPS by 36c
- Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
